Welcome to the sixth issue of Life Sciences Spotlight. In this issue, we explore a variety of topics and recent developments that are relevant to businesses operating in the life sciences sector in the Asia Pacific region and globally.
Highlights in this issue:
- Trends and developments in cyber security and data protection – Why pharma and life sciences companies should take action
- The Myriad of problems and opportunities continues – An update on the patentability of naturally occurring products in Australia and the US
- IMED: Telemedicine and the law
- Major trends give rise to competition concerns in the Australian life sciences sector
- Getting tough on corruption - Why businesses should take a closer look at their activities in Thailand
- International mobility and the need for upfront planning – A New Zealand perspective
- It's obvious – The Australian High Court rules on AstraZeneca’s Crestor® patent
- Pfizer / Hospira merger – Green light from New Zealand commerce commission to go with EU approval
- Pharmaceutical patent term extensions in the biotechnology sector in Australia